// App-Quantinova.ai

e12084 : The rational use of detection of CTC and serum HER2 ECD for HER2-positive advanced breast cancer patients. - Publication Only: Breast CancerHER2/ER

Researchers

Presenter

  • Jinmei Zhou

Principal Investigators

  • Tao Wang

  • Yi Liu

  • Huiqiang Zhang

  • Shaohua Zhang

  • Li Bian

  • Santai Song

  • Zefei Jiang

Medical Centers

  • Department of Breast Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

  • Department of Breast Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

  • Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

  • The Hospital Affiliated to Military Medical Science, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Ecdysoneless

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved